Rare Disease TherapiesTogether, we can bring hope and support to families impacted by rare diseases.
Our Story
Zogenix is committed to developing and commercializing transformative therapies to improve the lives of patients and their families living with rare diseases.
Investors
Zogenix, Inc. (NASDAQ: ZGNX) is committed to developing and commercializing transformative therapies for people living with rare diseases that can dramatically improve the lives of patients and their families.
Careers
We take pride in being a company who hires exceptional people who exemplify high standards and a passion to create significant value and benefits for healthcare professionals and their patients, our employees and our shareholders.
Clinical Trials
To view our open or completed clinical trials, please visit www.clinicaltrials.gov (U.S.) or www.clinicaltrialsregister.eu (EU) and search Zogenix or Modis Therapeutics, Inc.